Monday, August 3, 2020

DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India

According to the proposal, 1,600 people will participate in the trials
across 20 cities in the country, the health and family welfare
ministry said in a release on Monday.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/serum-gets-dcgi-nod-for-oxford-vaccine-trials/articleshow/77337121.cms

No comments:

Post a Comment